Literature DB >> 26681779

Long-Acting Injectable Preexposure Prophylaxis for HIV Prevention in South Africa: Is There a Will and a Way?

Raphael J Landovitz1, Beatriz Grinsztejn2.   

Abstract

Entities:  

Keywords:  HIV prevention; PrEP; antiretroviral agent; cost efficacy; extended release; long acting

Mesh：

Substances：

Year:  2015        PMID： 26681779     DOI： 10.1093/infdis/jiv524

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  3 in total

Review 1.  Long acting systemic HIV pre-exposure prophylaxis: an examination of the field.

Authors:  William R Lykins; Ellen Luecke; Daniel Johengen; Ariane van der Straten; Tejal A Desai
Journal:  Drug Deliv Transl Res       Date:  2017-12       Impact factor: 4.617

Review 2.  Strengths, weaknesses, opportunities and challenges for long acting injectable therapies: Insights for applications in HIV therapy.

Authors:  Andrew Owen; Steve Rannard
Journal:  Adv Drug Deliv Rev       Date:  2016-02-23       Impact factor: 15.470

Review 3.  Promise, perils and cautious optimism: the next frontier in long-acting modalities for the treatment and prevention of HIV.

Authors:  Morgan M Philbin; Amaya Perez-Brumer
Journal:  Curr Opin HIV AIDS       Date:  2022-03-01       Impact factor: 4.283
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.